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It is widely accepted that scientific evidence should play a role in policy decisions, yet the form that
this should or could take remains subject to intense debate. Warren Pearce and Sujatha
Raman discuss how the Making Science Public project attempts to address these questions.
The role of scientific evidence within policy is one of the most vexed issues within politics
and public administration. Often such evidence is complex, translated to the public via the
media and subsequently used to justify particular policy actions or seen to be ignored by
government ministers. This use, or perhaps abuse, of evidence can have implications for
political legitimacy, scientific authority and democratic participation and a host of efforts are
being made to alleviate this situation.
However, problems persist. 2012 saw a prolonged, and still unresolved, debate about the
effectiveness and ethics of culling badgers to arrest the spread of bovine tuberculosis in the
UK. This followed a series of flashpoints along the difficult boundary between science and
politics over the last 20 years: for example, the MMR vaccine debate challenged scientific
authority, Climategate led to questions over the integrity of scientific research and
the sacking of David Nutt called into question the status of scientific advice in policymaking.
In this post, we use the example of evidence-based policy to illuminate the recurring crises
of science and politics, and how one perceived solution – making science more public and
transparent – opens up a new set of challenging questions for science society.
People don’t understand the evidence…
For some, making science public involves putting evidence at the heart of how people and
politicians deliberate and make decisions on policy matters involving scientific research and
technology. Environmental campaigner Mark Lynas recently reversed his opposition to
genetically modified (GM) crops, proclaiming his change of heart to be a result of having
“discovered science”, objective scientific evidence trumping a naive green ideology.
However, it is too simplistic to believe that good policy is the result of merely discovering
and understanding the scientific evidence. For example, new evidence is emerging over the
threat posed to bees by neonicotinoid pesticides, demonstrating the difficulties of governing
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For others, therefore, making science public means opening up the matter of what counts as
valid evidence and how the central problem for policymaking is defined in the first place. Is it
right to introduce GM crops on the basis of evidence from the molecular sciences? Should
studies adopting different criteria of hazard be considered? Or should other factors be taken
into account, such as taking precautions against long term environmental effects, or
objections from organic farmers who fear contamination of their crops from new GM
varieties? How valid are the boundaries drawn between evidentiary and ethical matters? Is
the policy question just one of technological risk (to be resolved by science), or are there
public issues at stake? Similar quandaries over the use of evidence exist in drugs policy.
Some who call for politicians to listen to science also acknowledge that the line between
fact and opinion is not clear-cut; scientists examining evidence of harm from drugs, for
example, must necessarily make choices about what harms to consider and how to weigh
them up. Indeed, a significant section of the population may regard scientific evidence on
harms to health from drugs as peripheral to the formation of their views, preferring to see
prohibition as a moral issue.
So, it may well be that there is room for greater communication and public understanding of
particular evidence, but there is also the issue of making clear why particular forms of
evidence have been included or excluded from the decision-making process.
…so we need more openness, transparency and participation
A common response to these issues has been to make policy-making more open and
transparent. NESTA has called for a Red Book of Evidence, a place for government to lay
out all the evidence informing a particular policy, and illuminating the ‘audit trail’ which led
up to the decision. The UK government has introduced the notions of open and contestable
policy making (pdf, pp.14-15), acknowledging that much expertise exists beyond Whitehall,
and can make a significant contribution to policy making. Neither is the openness agenda
restricted to these shores, the UK government being a founding member of the Open
Government Partnership, an international network seeking to improve transparency and
civic participation throughout public affairs. A number of public participation exercises have
also been sponsored by government, in theory, to contribute to policymaking around new
technologies.
Such moves appear to address some of the factors behind the scientific controversies listed
at the start. Greater transparency in evidence usage may yet help explain how
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into Climategate found a “transformation in the need for openness in the culture of publicly
funded science” with increased scrutiny of climate science from those working outside
academic institutions.
But does open policymaking address the legitimacy problem?
These arguments for greater openness and transparency are often presented as clear-cut.
However, invoking these perceived public needs as a ‘solution’ to the crises around science
and policymaking brings two significant new questions. Firstly, if one moves from an
assumption of a singular ‘public’ towards acknowledging the presence of multiple publics in
society, then how might exercises in participation or transparency privilege certain publics
over others? Powerful private interests may be further bolstered under the guise of public
transparency, as multinational corporations and royalty gain even greater access to policy
makers. Public academic institutions may also be weakened, as open access publishing meant
to aid public access and understanding of research could actually enable private universities
to undercut tuition fees, using publicly-funded research to act as ‘free riders’. And if
transparency is dependent on access to sources of information online, then the nearly 11
million British people not using the internet will be further disempowered by being on the
wrong side of a widening digital divide.
Second, to what extent does the openness agenda actually allow debate on the core
questions of what counts as evidence and whether science should define the boundaries of
policy problems? Sponsored public dialogues can easily become exercises in claiming public
acceptance for policy decisions which have already been taken. If the legitimacy challenge for
evidence-based policymaking is about the social meaning of collective problems and who
gets to define it, it remains to be seen how this challenge can be addressed within the ‘open
policymaking’ movement.
Making Science Public: An emerging research agenda
This post has used evidence-based policy as an introduction to the broad range of debates,
challenges and opportunities which lie behind the idea of Making Science Public. It is a
research agenda straddling some of society’s most important and controversial topic areas:
food, agriculture and animals, energy and the environment, and health and social policy. As
well as transparency in policy making, the agenda looks towards the making of politics
through science and publics, alongside the role of public engagement and deliberation within
science and technology. Through these numerous perspectives on the idea of Making
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practice of democracy in the years to come.
The University of Nottingham is leading a 5-year research programme funded by the Leverhulme
Programme, Making Science Public (2012-2017), through which some of these questions
and related dilemmas will be investigated. The Programme is officially launched on 11th February
2013 with a day of dialogue and debate on what making science public means for people, science
and politics. Speakers include Ulrike Felt, Brigitte Nerlich, John Holmwood, Reiner
Grundmann, Brady Haran, Alice Bell, Alex Smith and the authors. If you would like to come along to
this free event and contribute to the debate, please register here. For regular updates from the
programme follow the Making Science Public blog and @MakingSciPub for news and research
relevant to the debate.
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